KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Microvision (MVIS) Operating Expenses (2020 - 2025)

Microvision (MVIS) has disclosed Operating Expenses for 10 consecutive years, with $25.3 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 58.12% to $25.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $65.5 million through Dec 2025, down 20.8% year-over-year, with the annual reading at $65.5 million for FY2025, 20.8% down from the prior year.
  • Operating Expenses hit $25.3 million in Q4 2025 for Microvision, up from $12.0 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $26.4 million in Q1 2024 to a low of $6.7 million in Q1 2021.
  • Historically, Operating Expenses has averaged $17.1 million across 5 years, with a median of $14.7 million in 2024.
  • Biggest five-year swings in Operating Expenses: skyrocketed 444.89% in 2021 and later plummeted 46.65% in 2025.
  • Year by year, Operating Expenses stood at $13.1 million in 2021, then increased by 6.34% to $14.0 million in 2022, then surged by 72.53% to $24.1 million in 2023, then plummeted by 33.55% to $16.0 million in 2024, then soared by 58.12% to $25.3 million in 2025.
  • Business Quant data shows Operating Expenses for MVIS at $25.3 million in Q4 2025, $12.0 million in Q3 2025, and $14.1 million in Q2 2025.